SCHEMBL7189262

SCHEMBL7189262

CCCc1cc(CCC)c(OC(C)C)c(C=CC(=O)c2ccc(NC)cc2)c1O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.36
PPARG P37231 3/20 0.35
PPARA Q07869 3/20 0.35
ABCG2 Q9UNQ0 1/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 2/20 0.34
KMT2A Q03164 2/20 0.34
RAB9A P51151 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7806545 1.00 CYP3A4 (0.36) CYP3A4PPARGPPARAABCG2MAPT
SCHEMBL7186120 0.91 CYP3A4 (0.38) CYP3A4ABCG2MAPTNPSR1KDM4E
SCHEMBL7186117 0.91 CYP3A4 (0.38) CYP3A4ABCG2MAPTNPSR1KDM4E
SCHEMBL7189637 0.89 ABCG2 (0.42) ABCG2MAPTMEN1ALDH1A1KMT2A
SCHEMBL7189632 0.89 ABCG2 (0.42) ABCG2MAPTMEN1ALDH1A1KMT2A
SCHEMBL7179071 0.89 ABCG2 (0.41) CYP3A4ABCG2MAPTNPSR1KDM4E
SCHEMBL7179069 0.89 ABCG2 (0.41) CYP3A4ABCG2MAPTNPSR1KDM4E
SCHEMBL7185218 0.88 MAOB (0.40) CYP3A4ABCG2MAPTNPSR1KDM4E
SCHEMBL7185214 0.88 MAOB (0.40) CYP3A4ABCG2MAPTNPSR1KDM4E
SCHEMBL7190872 0.88 CA1 (0.41) CYP3A4PPARGPPARAABCG2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed